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ABSTRACT  
Introduction: Tuberculosis is a major problem in the world which is need a focus treatment, 
particularly to prevent the spread and development of drug-resistant cases. Tuberculosis drug 
supervisor plays an important role in realizing government’s program “Indonesia without 
Tuberculosis in 2020”. The purpose of this study was to provide information about the correlation of 
drug supervisor activeness with motivation and medication compliance. Method: This study was a 
cross sectional approach. The population was patients who underwent pulmonary TB treatment in 
Puskemas (Public Health Center) Pare and Sidorejo. The respondent were 35 patient taken by 
purposive sampling. The independent variable was the activeness of the drug supervisor, while the 
dependent variable was motivation and Tuberculosis medication adherence. Collecting data used 
questionnaire and was analyzed using Chi Square statistical tests with significance at level <0.05. 
Result: Statistical results showed significant correlations between the drug supervisor activeness with 
the patient's motivation (p=0.000) and adherence to ingest drugs Pulmonary Tubercoluse (p=0.001); 
either between motivation and adherence to ingest drugs Pulmonary Tubercoluse (p=0.011). 
Discussion: Drug supervisor has to actively motivate patient with tuberculosis in order to increase 
their medication adherence. Health care unit could enhance the drug supervisor activeness and 
patient’s motivation in order to prevent the spread of tuberculosis. 
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 INTRODUCTION 
Tuberculosis is a major health problem 
in the tropical countries, particularly 
Indonesia. Tbuerculosis (Tb) medication 
program implemented in the form of DOTS 
(Directly Observe Treatment Shortcourse) 
which requires the role of drug supervisor (in 
bahasa: PMO- Pengawas Menelan Obat) to 
ensure patient’s medication compliance. Drug 
supervisor is a person who is well known to 
both patients and health care workers who will 
participate in supervising the patients in taking 
the drugs of Tuberculosis.  
In 2013, pulmonary tuberculosis 
patients in Indonesia recorded 9 million people 
and 3.5% were MDR Tb. Indonesia ranked 8th 
out of 27 countries with the burden of MDR 
Tb patients were 6900 (WHO, 2013). Kediri 
had an increasing number of  pulmonary TB 
patients as much as 4.55% during 2013-2014 
and only 6.21% patients could completed the 
medication in 2014 (Kediri’s Health Profile 
2014). 
The incidence of MDR-Tb is basically 
as a result of inadequate treatment. The cause 
of inadequate treatment is influenced by non-
adherent patients in taking the drug, have no 
drug supervisor or inactiveness of the drug 
supervisor in carrying out its roles (Infodatin, 
2015). This study aimed to determine the 
correlation  of the drug supervisor with the 
motivation and adherence in taking the drug 
among patients with pulmonary tuberculosis. 
Theory of behaviour of Lawrence Green 
that human behavior is influenced by three 
factors, (1) the predisposing factors that are 
internal factors that exist in individuals; (2) 
enabling factors that established in the 
physical environment, the availability of 
facilities or health facilities, such as health 
centers, medicines, and so on; and (3) 
reinforcing factor which are the family, 
teachers, health workers, community leaders, 
and decision makers. The successful of Tb’s 
treatment requires the awareness of the patient 
that both of the treatment phases has to fully 
implemented, even they feel no symptoms of 
Tb. In other words, if the intensive phase of 
treatment compliance is not followed by a 
continuation phase of compliance would result 
in patients experiencing treatment failure. The 
family as a drug supervisor also has a role to 
remind and motivate patients to take anti-
tuberculosis drugs on schedule in any 
condition (Sumarman, 2011). Therefore, 
during the treatment period required good 
cooperation and continuously between a drug 
supervisor with the patient in completing the 
medication (Purwata, 2005). 
 
MATERIALS AND METHODS 
This was a descriptive correlation with 
cross sectional design. The samples were taken 
from all patients with pulmonary Tb in the 
working area of UPTD Puskesmas Sidorejo 
and Pare in Kediri as many as 35 people, 
consisting of 21 patients in intensive phase of 
medication and 14 patients in continuation 
phase of medication. This study was used 
purposive sampling. The independent variable 
was the activeness of drug supervisor based on 
Indonesian Guidelines of Treatment of 
Pulmonary Tuberculosis (2011). In other hand, 
the dependent variables in this study were the 
motivation and the medication adherence of 
pulmonary Tb patients. The data was 
conducted using questionnaires, (1) 
questionnaire of the activeness of drug 
supervisor that was containing of 12 
statements, (2) the motivation in completing 
medication that was containing of 15 
statements, and (3) questionnaire of the 
medication adherence that was adopted from 
the MMAS-8 (Medication Adherence Morisky 
Scale). Analysis of data were using statistical 
test of Chi Square with ≤0,05. 
 
RESULTS 
Table 1 shows that the majority of 
respondents were female (60%), and were in 
the age range between 21-30 years (42.8%). In 
addition, respondent’s recent education are 
mostly at high school (60%), most have 
suffered from pulmonary tuberculosis for <2 
months (60%), and the drug supervisors were 
mostly their wives or children (65.6%). 
 
Table 1. Characteristics of respondents  
Characteristics f % 
Sex     
Male 14 40 
Female 21 60 
n 35 100 
Age     
< 20 tahun 
  
21 tahun - 30 tahun 15 42,8 
31 tahun - 40 tahun 14 40,0 
>40 tahun 6 17,2 
n 35 100 
Education     
Elementary School   2 5,7  
Junior High School 8 22,8 
Senior High School 21 60 
Higher Educations 4 11,5 
n 35 100 
Profession 
 
  
Farmer  5 14,2 
Private Labor 11 31,5 
Entrepreneur 6 17,3 
Civil Servant 1 2,8 
Others 12 34,2 
n 35 100 
Drug Supervisor     
Father  2 5,7  
Mother 
  
Husband 4 12,6 
Wife 10 28,5 
Child 13 37,1 
Brother or sister 4 11,4 
Others 2 5,71 
n 35 100,0 
Duration of Ilness (Tb) 
  
< 2 months 21 60 
>2 months 14 40 
n 35 100 
  
 
Table 2. Cross tabulation and statistical result 
of  the activeness of the drug 
supervisor with the motivation of 
pulmonary Tb patient 
The 
activeness 
of the drug 
supervisor 
Motivation Sum 
 (n) 
  
High  Low 
f % f % f % 
Active 21 60,0 4 11,4 25 71,4 
Inactive  1 2,9 9 25,7 10 28,6 
n 22 62,9 13 37,1 35  100 
Chi Square test                            p = 0,000 ; < 0,05 
 
 
 
Table 2 shows that mostly respondents 
have an active drug supervisor (71,4%). In 
other hand, even though the patient has had an 
active drug supervisor, some of them still have 
low motivation in Tb medication (11,4%). In 
the other hand, there was one patient have an 
inactive drug supervisor but he had a high 
motivation in medication (2,9%). In addition, 
Chi Square test showed that value of p = 0.000 
( <0.05), which means there was a 
correlation between the activeness of the drug 
supervisor with the motivation of pulmonary 
Tb patient. 
 
Table 3. Cross tabulation and statistical result 
of  the activeness of the drug 
supervisor with the compliance of 
pulmonary Tb Patient 
The 
activeness 
of the drug 
supervisor 
Compliance  Sum 
(n) High Medium Low 
f % f % 
f % 
f % 
Active 15 42,8 10 28,6 0 0,0 25 100 
Inactive  0 0,0 7 20,0 3 8,6 10 100 
n 15 42,8 17 48,6 3 8,6 35 100 
Chi Square test                           p = 0,001 ; < 0,05 
 
 
Table 3 shows that mostly Tb patients 
that had have an active drug supervisor also 
have a high compliance in the treatment  at the 
same time (42,8%). In other hand, there were 
no Tb patients with an inactive drug 
supervisors had have a high compliance in the 
treatment. The result of Chi Square test 
showed that p value = 0.001 ( <0.05), which 
means there was a correlation between the 
activeness of the drug supervisor with the 
compliance of pulmonary Tb patients. 
 
Table 4. Cross tabulation and statistical result 
of  the motivation with the compliance of 
pulmonary Tb Patient  
 
Motivati
on 
Compliance Sum 
(n) High Medium Low 
f % f % f % f % 
High 12 34,3 10 28,6 0 0,0 22 100 
Low 3 8,5 7 20 3 8,6 13 100 
n 15 42,8 17 48,6 3 8,6 35   100 
Chi Square test                p = 0,029 ; < 0,05 
 
 
Table 4 shows that the majority of 
respondents had a medium compliance.  In the 
other hand, mostly respondents had a high 
motivation. Interestingly, there were some 
respondents had a low motivation, but they 
showed a high compliance in the treatment of 
Tb. The results of Chi Square test showed p 
value = 0.029 ( <0.05), which means there 
was a relationship between motivation with 
pulmonary Tb patient compliance.  
 
 
DISCUSSION 
The statistical test showed a significant 
correlation between the drug supervisor’s 
activeness with the motivation of Tb patients 
in UPTD Puskesmas Pare and UPTD 
Puskesmas Sidorejo. This is in accordance 
with national guidance book Pulmonary TB 
control that includes about the tasks of the 
drug supervisor.  One of them is giving a boost 
to the pulmonary TB patients (Ministry of 
Health, 2011). It is also consistent with the 
results of research conducted by Pare (2013) 
which states that the relationship the drug 
supervisor active role in increasing the 
motivation of pulmonary TB patients to 
recover, and the active role of the drug 
supervisor into the risk factors related to 
behavior treatment of pulmonary TB patients. 
 
Pulmonary TB is a curable disease for a 
long time, it takes a long time and continuous, 
boredom took the drug despite signs symptoms 
gradually disappeared already occurs 
frequently in patients with pulmonary 
tuberculosis, for the liveliness the drug 
supervisor is important to give encouragement 
to patients with pulmonary tuberculosis. A 
total of 21 drug supervisors active is able to 
provide a good motivation, but as much as 4 
drug supervisors either not capable of 
describing the motivation both TB patients and 
1 drug supervisor inactive but patients have a 
good motivation contained in respondent 
number 23 were female, educated past high 
school , in the range of 20-30 years of age with 
TB more than two months, and which became 
the the drug supervisor is the father, this is 
because according to L. Green motivation is 
not only affected by the drug supervisor, but 
also influenced by teachers, peers, health 
workers, and public figure. A total of 6 people 
the drug supervisor also as the wife of the 
respondents were able to give a good 
motivation to the respondents, it is also 
supported by Herryanto (2004) which 
describes the factors that support women the 
drug supervisor is in terms of attention and the 
opportunity to accompany the patient. But the 
need to watch out the possibility of a decline 
in motivation of the drug supervisor in 
performing their duties, because the biggest 
obstacle faced by the drug supervisor is the 
people who are bored/tired of taking 
medication. 
 
The analysis shows that there is 
significant correlation between the activity of 
the drug supervisor with pulmonary TB patient 
compliance in UPTD Puskesmas Pare and 
UPTD Puskesmas Sidorejo. The results of this 
analysis is supported by the results of research 
and Krisnawati Sumarman (2013) who found 
that the role of the drug supervisor unfavorable 
risk for 3 times to cause non-adherent patients 
sputum check back on the final phase of 
treatment compared with patients who have an 
active role of the drug supervisor. Similarly 
discovered by Abdurahim (2006) that there is 
a relationship between the activity of the drug 
supervisor with treatment compliance patients 
with pulmonary TB, but this does not rule out 
the possibility of a failure of pulmonary TB 
patients with liveliness the drug supervisor, 
this is due to factors affecting patient 
adherence Pulmonary TB not only on the 
activity the drug supervisor alone, but of 
patient factors and environmental factors. TB 
disease is strongly associated with the patient's 
behavior and environmental factors. 
Environmental factors such as housing 
conditions (ventilation, sanitation) is very 
influential on the existence of germs, and the 
process of arising and transmission. 
 
Pulmonary TB treatment requires a long 
period of time between 6-9 months, it is that 
makes people have less desire to heal because 
of despair and, as well as the high risk of 
failure to comply MDR Tb in sputum 
examined and swallow the medicine. To 
ensure compliance swallowing the drug, then 
the need for the drug supervisor’s role in 
overseeing any patient taking the medication. 
Accompanied by the drug supervisor in any 
activities examined sputum or swallowing the 
drug is expected Pulmonary TB cure rate can 
reach 100%. 
 
The analysis showed that a significant 
relationship between motivation and 
compliance of pulmonary TB patients in 
UPTD Puskesmas Pare and Puskesmas UPTD 
Sidorejo. This is according to research 
conducted by Prasetya (2009), motivation is 
the key to success, the higher the motivation of 
the more obedient, in this case the medication 
adherence in following the DOTS program. 
Therefore in an effort to anticipate non-
compliance with treatment in patients with 
pulmonary tuberculosis is necessary to deliver 
information as accurately as possible, by 
holding health education carried out by each 
health service. According to Spencer that good 
manners are supported from a high motivation, 
without motivation people can not do anything 
and will not move. Motivation is the driving 
force, in the presence of human motivation 
will move faster activities, it is important and 
perceived as a necessity. Motivation is the key 
to success, the higher the motivation of the 
more submissive in this case is to take 
medication compliance in the program. 
A total of 12 respondents who have a good 
motivation also have good adherence levels 
anyway, but 3 respondents have good 
adherence levels, this suggests that the 
motivation to give a lot of influence on the 
level of compliance with medication ingestion 
of pulmonary TB patients, but there are still 
many factors that influence the behavior 
compliance, in accordance with the theory of 
L. Green behavior not only by motivation, but 
also knowledge, attitudes, beliefs, values / 
norms, health facilities, health regulations, 
teachers, community leaders, etc. 
   
CONCLUSIONS AND 
RECOMMENDATIONS 
Conclusions 
1. The majority of patients with pulmonary 
TB in UPTD Puskesmas Pare and 
Sidorejo have active drug supervisors. 
2. The majority of patients with pulmonary 
TB in UPTD Puskesmas Pare and 
Sidorejo have a good motivation. 
3. The majority of patients with pulmonary 
TB in UPTD Puskesmas Pare and 
Sidorejo have a low level of compliance. 
4. There was a significant correlation 
between the activeness of the drug 
supervisor with the motivation of 
pulmonary TB patients in UPTD 
Puskesmas Sidorejo and Pare Kediri. 
5. There was significant correlation between 
the activeness of the drug supervisor to 
compliance with medication ingestion of 
pulmonary TB patients in UPTD 
Puskesmas Pare and Sidorejo Kediri. 
6. There was a significant association 
between compliance with motivation of  
pulmonary TB patients in Kediri. 
 
Recommendations 
1. Nurse should increase the activeness of the 
drug supervisor by providing guidance on 
the role of the drug supervisor in the DOTS 
program in order to achieve 100% free of 
TB. 
2. Increase the motivation to recover, because 
given the TB disease is not cured only by 1 
or 2x treatment, but need treatment 
completely. 
3. Improving compliance in Pulmonary TB 
treatment because it is not just one kind of 
drug but a variety of combinations of drugs 
used to cure it. 
4. Do more research to measure other 
variables in full accordance with the theory 
of Lawrence Green. 
5. Further research by using a questionnaire 
from the other perspective of the drug 
supervisor. 
6. Conduct further research on medication 
adherence and the activeness of the drug 
supervisor with the observatory method, so 
that the results more objectively. 
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